Uyl-de Groot, C.A.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Economic evaluations of big data analytics for clinical decision-making: a scoping review

Bakker, Lytske, Aarts, Jos, Uyl-de Groot, Carin, Redekop, William

Journal:

Journal of the American Medical Informatics Association

Year:

2020

File:

PDF, 409 KB

2020

2

A systematic literature review and network meta-analysis of effectiveness and safety outcomes in advanced melanoma

Franken, Margreet G., Leeneman, Brenda, Gheorghe, Maria, Uyl-de Groot, Carin A., Haanen, John B.A.G., van Baal, Pieter H.M.

Journal:

European Journal of Cancer

Year:

2019

Language:

english

File:

PDF, 726 KB

english, 2019

3

Novel anticancer agents for multiple myeloma: a review of the evidence for their therapeutic and economic value

Gaultney, Jennifer G, Redekop, William K, Sonneveld, Pieter, Uyl-de Groot, Carin A

Journal:

Expert Review of Anticancer Therapy

Year:

2012

Language:

english

File:

PDF, 539 KB

english, 2012

4

A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia

Kloos, Robin Q. H., van Litsenburg, Raphaële R. L., Wolf, Sarah, Wismans, Leonoor, Kaspers, Gertjan J. L., Uyl-de Groot, Carin A., Pieters, Rob, van der Sluis, Inge M.

Journal:

Pediatric Blood & Cancer

Year:

2018

Language:

english

File:

PDF, 410 KB

english, 2018

5

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry

Blommestein, Hedwig M., Franken, Margreet G., Uyl-de Groot, Carin A.

Journal:

PharmacoEconomics

Year:

2015

Language:

english

File:

PDF, 300 KB

english, 2015

6

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

Silvia G. R. Verelst, F. Termorshuizen, C. A. Uyl-de Groot, M. R. Schaafsma, A. H. M. Ammerlaan, S. Wittebol, H. A. M. Sinnige, S. Zweegman, M. van Marwijk Kooy, R. van der Griend, H. M. Lokhorst, P.

Journal:

Annals of Hematology

Year:

2011

Language:

english

File:

PDF, 274 KB

english, 2011

7

Treatment patterns and differences in survival of non-small cell lung cancer patients between academic and non-academic hospitals in the Netherlands

van der Linden, Naomi, Bongers, Mathilda L., Coupé, Veerle M.H., Smit, Egbert F., Groen, Harry J.M., Welling, Alle, Schramel, Franz M.N.H., Uyl-de Groot, Carin A.

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 822 KB

english, 2015

8

One Line Does Not Make a Picture: Real-World Cost-Effectiveness of Multiple Myeloma Treatments Using a Full Disease Model

Blommestein, H., Verelst, S., de Groot, S., Huijgens, P., Sonneveld, P., Uyl-de, G.root C

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 59 KB

english, 2013

9

Assessment of Studies Evaluating Incremental Costs, Effectiveness, or Cost-Effectiveness of Systemic Therapies in Breast Cancer Based on Claims Data: A Systematic Review

Luyendijk, Marianne, Vernooij, Robin W.M., Blommestein, Hedwig M., Siesling, Sabine, Uyl-de Groot, Carin A.

Journal:

Value in Health

Year:

2020

File:

PDF, 288 KB

2020

10

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks

Gronde, Toon van der, Uyl-de Groot, Carin A., Pieters, Toine, Mihalopoulos, Cathy

Journal:

Year:

2017

Language:

english

File:

PDF, 2.88 MB

english, 2017

11

Sustainability and affordability of cancer drugs: a novel pricing model

Uyl-de Groot, Carin A., Löwenberg, Bob

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Year:

2018

Language:

english

File:

PDF, 412 KB

english, 2018

12

Critical review of economic evaluations in multiple myeloma: An overview of the economic evidence and quality of the methodology

Jennifer G. Gaultney, W.K. Redekop, Pieter Sonneveld, Carin A. Uyl-de Groot

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 615 KB

english, 2011

13

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits

C.A. Uyl-de Groot, J.B. Vermorken, M.G. Hanna Jr., P. Verboom, M.T. Groot, G.J. Bonsel, C.J.L.M. Meijer, H.M. Pinedo

Journal:

Year:

2005

Language:

english

File:

PDF, 180 KB

english, 2005

14

Experience with outcomes research into the real-world effectiveness of novel therapies in Dutch daily practice from the context of conditional reimbursement

Gaultney, Jennifer G., Franken, Margreet G., Uyl-de Groot, Carin A., Redekop, William K., Huijgens, Peter C., van der Holt, Bronno, Lokhorst, Henk M., Sonneveld, Pieter

Journal:

Year:

2015

Language:

english

File:

PDF, 567 KB

english, 2015

15

Measurement and valuation of quality of life in economic appraisal of cancer treatment

Uyl-de Groot, C.A., Rutten, F.F.H., Bonsel, G.J.

Journal:

European Journal of Cancer

Year:

1994

Language:

english

File:

PDF, 646 KB

english, 1994

16

Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial

Prick, BW, Jansen, AJG, Steegers, EAP, Hop, WCJ, Essink-Bot, ML, Uyl-de Groot, CA, Akerboom, BMC, van Alphen, M, Bloemenkamp, KWM, Boers, KE, Bremer, HA, Kwee, A, van Loon, AJ, Metz, GCH, Papatsonis,

Journal:

BJOG: An International Journal of Obstetrics & Gynaecology

Year:

2014

Language:

english

File:

PDF, 234 KB

english, 2014

17

Cost–utility of sentinel lymph node biopsy in cT1–T2N0 oral cancer

van der Linden, Naomi, Flach, Géke B., de Bree, Remco, Uyl-de Groot, Carin A.

Journal:

Year:

2016

Language:

english

File:

PDF, 818 KB

english, 2016

18

Cancer in the oropharynx: Can we prioritize treatment modalities based on costs of primary treatment, anticipated relapses and grade III/IV complications

P.C. Levendag, W. Nijdam, I. Noever, C. Uyl-de Groot, M. vanAgthoven

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2004

Language:

english

File:

PDF, 67 KB

english, 2004

19

Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukaemia

Uyl-DE Groot, LÖwenberg, Vellenga, Suciu, Willemze, Rutten

Journal:

British Journal of Haematology

Year:

1998

Language:

english

File:

PDF, 327 KB

english, 1998

20

The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands

Leunis, Annemieke, Blommestein, Hedwig M., Huijgens, Peter C., Blijlevens, Nicole M.A., Jongen-Lavrencic, Mojca, Uyl-de Groot, Carin A.

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 466 KB

english, 2013

21

Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck

van der Linden, N., van Gils, C. W. M., Pescott, C. P., Buter, J., Vergeer, M. R., Groot, C. A. Uyl-de

Journal:

European Archives of Oto-Rhino-Laryngology

Year:

2015

Language:

english

File:

PDF, 790 KB

english, 2015

22

Costs of Diagnosis, Treatment, and Follow Up of Patients with Acute Myeloid Leukemia in the Netherlands

Uyl-de Groot, C.A., Gelderblom-den Hartog, J., Huijgens, P.C., Willemze, R., van Ineveld, B.M.

Journal:

Journal of Hematotherapy & Stem Cell Research

Year:

2001

Language:

english

File:

PDF, 144 KB

english, 2001

23

A Multi-State Model of Metatstatic Colorectal Cancer

van Rooijen, E.M., Coupé, V.M.H., Koopman, M., Punt, C.J.A., Uyl-De, Groot C.A.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 63 KB

english, 2014

24

Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D

Versteegh, M. M., Leunis, A., Luime, J. J., Boggild, M., Uyl-de Groot, C. A., Stolk, E. A.

Journal:

Medical Decision Making

Year:

2012

Language:

english

File:

PDF, 518 KB

english, 2012

25

Real-world costs of laboratory tests for non-small cell lung cancer

van der Linden, Naomi, Smit, Egbert F., Uyl-de Groot, Carin A.

Journal:

Clinical Chemistry and Laboratory Medicine

Year:

2015

Language:

english

File:

PDF, 428 KB

english, 2015

26

Potential Therapeutic and Economic Value of Risk-Stratified Treatment as Initial Treatment of Multiple Myeloma in Europe

Gaultney, JG, Ng, T, Uyl-de Groot, CA, Sonneveld, P, van Beers, EH, van Vliet, MH, Redekop, WK

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 86 KB

english, 2017

27

PCN85 - SAVING HEALTHCARE AND SOCIETAL COSTS BY CHANGING THE ROUTE OF ADMINISTRATION OF ONCOLOGY DRUGS

Franken, M.G., Kanters, T.A., Coenen, J.L., de Jong, P., Koene, H.R., Lugtenburg, P.J., Jager, A., Uyl-de Groot, C.A.

Journal:

Value in Health

Year:

2018

Language:

english

File:

PDF, 375 KB

english, 2018

28

Difficult epidural placement in obese and non-obese pregnant women – A systematic review and meta-analysis

Uyl, N., de Jonge, E., Uyl-de Groot, C., van der Marel, C., Duvekot, J.

Journal:

International Journal of Obstetric Anesthesia

Year:

2019

Language:

english

File:

PDF, 671 KB

english, 2019

29

PCN418 ASSESSMENT OF STUDIES EVALUATING INCREMENTAL COSTS, EFFECTIVENESS OR COST-EFFECTIVENESS OF SYSTEMIC THERAPIES IN BREAST CANCER BASED ON CLAIMS DATA: A SYSTEMATIC REVIEW

Luyendijk, M., Vernooij, R.W.M., Blommestein, H.M., Siesling, S., Uyl-de Groot, C.A.

Journal:

Value in Health

Year:

2019

File:

PDF, 378 KB

2019

30

PNS410 DATA FROM EXPANDED ACCESS PROGRAMS: TREATMENT FIRST, COLLECTION SECOND. AN OVERVIEW OF FDA AND EMA REGULATORY APPROVALS.

Polak, T., Uyl-de Groot, C.A., Van Rosmalen, J.

Journal:

Value in Health

Year:

2019

Language:

english

File:

PDF, 383 KB

english, 2019

31

PD.18 Can we prioritize treatment modalities for oropharyngeal cancer based on costs of primary treatment, relapse, and grade III/IV complications?

M. van Agthoven, W.M. Nijdam, P.C. Levendag, I. Noever, C.A. Uyl-de Groot

Journal:

Oral Oncology Supplement

Year:

2005

Language:

english

File:

PDF, 128 KB

english, 2005

32

PCN22 COSTS OF COMMON TREATMENT OPTIONS FOR INDOLENT FOLLICULAR NON-HODGKIN'S LYMPHOMA

M Van Agthoven, A Hagenbeek, CA Uyl-de Groot

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 64 KB

english, 2005

33

UT1 The Calculation of Quality of Life Utilities for Acute Leukemia: A Comparison Between EQ5D-5L and QlQ-C30

A. Leunis, W.K. Redekop, B. Lowenberg, C. Uyl-de Groot

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 57 KB

english, 2012

34

1054 Cost analysis comparing brachytherapy versus surgery for carcinoma of the tonsillar fossa and/or soft palate

Nijdam, W., Levendag, P., Noever, I., Uyl-de Groot, C., van, M.Agthoven

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

35

Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (Filgrastim); a Less costly alternative to autologous bone marrow transplantation

Groot, C.A.Uyl-de, Richel, D.J., Rutten, F.F.H.

Journal:

European Journal of Cancer

Year:

1994

Language:

english

File:

PDF, 597 KB

english, 1994

36

PSY39 REAL-WORLD COST-EFFECTIVENESS OF BORTEZOMIB IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN THE NETHERLANDS

Gaultney, J, Franken, M, Huijgens, PC, Sonneveld, P, Uyl-De, Groot C, Redekop, WK

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 79 KB

english, 2010

37

The Drug Reimbursement Decision-Making System in Iran

Ansaripour, Amir, Uyl-de Groot, Carin A., Steenhoek, Adri, Redekop, William K.

Journal:

Value in Health Regional Issues

Year:

2014

Language:

english

File:

PDF, 608 KB

english, 2014

38

The economics of improved cancer survival rates: better outcomes, higher costs

Uyl-de Groot, Carin A, Groot, Saskia de, Steenhoek, Adri

Journal:

Expert Review of Pharmacoeconomics & Outcomes Research

Year:

2010

Language:

english

File:

PDF, 521 KB

english, 2010

39

DIFFERENCES IN CARE BURDEN OF PATIENTS UNDERGOING DIALYSIS IN DIFFERENT CENTRES IN THE NETHERLANDS

de Kleijn, Ria, Uyl-de Groot, Carin, Hagen, Chris, Diepenbroek, Adry, Pasker-de Jong, Pieternel, ter Wee, Piet

Journal:

Journal of Renal Care

Year:

2017

Language:

english

File:

PDF, 103 KB

english, 2017

40

PAM5 A SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF INTERVENTIONS WITH A PERSONALIZED NUTRITION COMPONENT IN ADULTS

Galekop, M., Uyl-de Groot, C.A., Redekop, W.K.

Journal:

Value in Health

Year:

2019

File:

PDF, 321 KB

2019

41

Uitkomstenonderzoek: een definitie is dringend gewenst

A. Steenhoek, C. A. Uyl-de Groot, F. F. H. Rutten

Journal:

Tijdschrift voor gezondheidswetenschappen

Year:

2008

Language:

dutch

File:

PDF, 55 KB

dutch, 2008

42

A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma: a prospective randomised phase III study

M. van Agthoven, C.M. Segeren, I. Buijt, C.A. Uyl-de Groot, B. van der Holt, H.M. Lokhorst, P. Sonneveld

Journal:

European Journal of Cancer

Year:

2004

Language:

english

File:

PDF, 334 KB

english, 2004

43

PCN12 EXPLORING THE ROLE OF OUTCOMES RESEARCH IN DUTCH REIMBURSEMENT POLICY: REAL-WORLD PHARMACOECONOMICS OF OXALIPLATIN IN STAGE III COLON CANCER

CWM van Gils, WK Redekop, CJA Punt, CA Uyl-de Groot

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 79 KB

english, 2009

44

PCN51 POTENTIAL ECONOMIC AND HEALTH IMPACT OF GENOMICS AND PROTEOMICSTECHNOLOGY FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA

WK Redekop, H Vietor, B Lowenberg, CA Uyl-de Groot

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 69 KB

english, 2008

45

THE SERVICES.

Groot, C.A.Uyl-de, Richel, D.J., Rutten, F.F.H.

Journal:

Year:

1895

Language:

english

File:

PDF, 412 KB

english, 1895

46

PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell Carcinoma

De groot, S., Redekop, W., Kiemeney, L., Uyl-de Groot, C.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 68 KB

english, 2011

47

NORTH LONDON MEDICAL AND CHIRURGICAL SOCIETY.

Ansaripour, Amir, Uyl-de Groot, Carin A., Steenhoek, Adri, Redekop, William K.

Journal:

Year:

1895

Language:

english

File:

PDF, 207 KB

english, 1895

48

Costs of Peripheral Blood Progenitor Cell Transplantation Using Whole Blood Mobilised by Filgrastim as Compared With Autologous Bone Marrow Transplantation in Non-Hodgkin’s Lymphoma

Carin A. Uyl-de Groot,Gert J. Ossenkoppele,Ivanne Buijt…

Journal:

PharmacoEconomics

Year:

1999

Language:

english

File:

PDF, 98 KB

english, 1999

49

The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis

Dr Leida M. Lamers,Carin A. Uyl-de Groot,Ivonne Buijt

Journal:

PharmacoEconomics

Year:

2007

Language:

english

File:

PDF, 123 KB

english, 2007

50

Real-world resource use and costs of adjuvant treatment for stage III colon cancer

van Gils, C.W.M., de Groot, S., Tan, S.S., Redekop, W.K., Koopman, M., Punt, C.J.A., Uyl-de Groot, C.A.

Journal:

European Journal of Cancer Care

Year:

2014

Language:

english

File:

PDF, 181 KB

english, 2014

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски